Kikuchi disease is a rare benign lesion usually affecting the lymph nodes of the whole body, and its hypermetabolic features on 18 F-FDG PET/CT may be confused with those of infection, metastasis or primary malignancy. I report a case of Kikuchi disease of the axillary lymph node (LN) showing increased FDG uptake on 18 F-FDG PET/CT mimicking a metastatic lymphadenopathy (LAP) in a 40-year-old patient with right breast cancer (Fig. 1) .
A 40-year-old female had been diagnosed with intraductal carcinoma of the right breast and successfully treated with chemotherapy and surgical resection 5 years ago. She had no complaints of pain, fever or palpation of a mass in her right axilla after surgery.
An 18 F-FDG PET/CT scan (Biograph 2, Siemens, Germany) was performed after the injection of 351.5 MBq (9.5 mCi) of 18 F-FDG with a blood glucose level of 88 mg/dl for restaging.
18
F-FDG PET/CT showed an increased FDG uptake of the enlarged LN in the right axilla with a maximum standardized value (SUVmax) of 4.0, which could not exclude ipsilateral metastatic LAP. The chest CT images revealed an enhancing LAP in the right axilla that appeared to be a metastatic LAP. Because the imaging studies failed to demonstrate the benign nature of this lesion, an LN dissection of the lesion was performed. The histology showed subacute necrotizing lymphadenitis with reactive hyperplasia, which suggested Kikuchi disease.
Kikuchi disease, a subacute necrotizing histiocytic lymphadenitis, is a rare benign and self-limited disease usually presenting as a lymphadenopathy with fever of the affected LNs, mainly characterized by cervical LAP. Other lymph nodes, such as the axillary or abdominal ones, may be less frequently involved, and generalized lymphadenopathy is uncommon [1] . Clinically and histologically, Kikuchi diease can be misdiagnosed as lymphoid malignancy, metastatic LAPs or an infectious disease. Kikuchi-Fujimoto disease is generally diagnosed on the basis of an excisional biopsy of a lymph node and histopathology. Accurate diagnosis of Kikuchi disease by histology is essential to avoid an unnecessary or incorrect treatment plan associated with the diagnosis of malignancy, metastasis or infection. [2] .
Several reports on the use of 18 F-FDG PET/CT in Kikuchi disease can be found in the literature. [3] [4] [5] [6] [7] [8] , which reported having definite FDG uptake in affected LNs and receiving helpful information from the histologic diagnosis on the distribution and metabolic activity of regional or generalized LAPs or recurrence.
This report indicates that Kikuchi disease should be considered in the differential diagnosis of axillary LAP found on 18 F-FDG PET/CT with increased tracer uptake in patients with breast cancer.
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